Pick up The EPNextS Group News
-
EPS Group 2026.07.16“EPS BIOPath”, EPS Launches a New End-to-End Support Service for Biotech Companies Entering Japan— Providing Collaborative Support in Japan from Development Strategy to Execution —
-
Information 2026.06.02EPNextS Group to Exhibit at DIA 2026 and BIO 2026 — Meet Our Team in Person
-
Information 2025.08.18EPNextS Featured in Newsweek International
-
Press Release 2025.05.21EPNextS, Inc. Achieves Science Based Targets (SBT) Certification
ARCHIVE
-
2025.05.21 Press Release
EPNextS, Inc. Achieves Science Based Targets (SBT) Certification
-
2025.05.19 Information
EPNextS to Exhibit at BIO International Convention 2025
-
2025.05.19 Information
EPNextS to Exhibit and Present Poster at DIA 2025 Global Annual Meeting
-
2025.05.01 Press Release
Announcement on Changes to the Board of Directors of EPNextS Inc.
-
2025.04.02 Information
J-ENTRY Consortium, in which EPS Group Participates, Featured in Fierce Pharma
-
2025.03.19 Press Release
Three Companies in the EPNextS Group—EPS Corporation, EP-Link Co., Ltd., and EP-PharmaLine Co., Ltd. —Recognized as “2025 Certified Health & Productivity Management Outstanding Organizations (Large Enterprise Category)”
-
2025.03.06 Press Release
Notice Regarding the Executive Officers and Management Structure of EPNextS, Inc. and its Group Companies
-
2024.09.18 Press Release
Results from the CIRCULATE-Japan GALAXY Study, a Joint Research Project between the EPNextS Group and the National Cancer Center Japan, Published in Nature Medicine
-
2024.03.21 Press Release
EPNextS Group will collaborate with Frontage Laboratories, Inc. for Early Phase Clinical Trial and Clinical Site Management in the United States to Improve “Drug Lag” and “Drug Loss” Issues in Japan.
-
2024.03.11 Press Release
NTT DATA and EPNextS Start Collaboration to Promote the Utilization of Electronic Medical Record Data